MEDICUS PHARMA LTD. Other Comprehensive Income (Loss), Tax
MEDICUS PHARMA LTD. (MDCX) reported Other Comprehensive Income (Loss), Tax of $255.18 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossTax · last filed 2026-08-12
- MEDICUS PHARMA LTD. other comprehensive income (loss), tax for the quarter ending 2026-06-30 was $255.18K.
- MEDICUS PHARMA LTD. other comprehensive income (loss), tax for the quarter ending 2026-03-31 was -$204.25K.
- MEDICUS PHARMA LTD. other comprehensive income (loss), tax for the quarter ending 2025-09-30 was $10.83K.
- MEDICUS PHARMA LTD. other comprehensive income (loss), tax for fiscal 2025 was $10.73K.
| Period end | Other Comprehensive Income (Loss), Tax 3 month | Other Comprehensive Income (Loss), Tax 6 month | Other Comprehensive Income (Loss), Tax 12 month |
|---|---|---|---|
| 2026-06-30 | $255.18K 10-Q · filed 2026-08-12 | $50.93K derived: sum of 2 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$204.25K 10-Q · filed 2026-08-12 | ||
| 2025-12-31 | $10.73K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $10.83K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |